Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia
- Teh, B.
- Grayson, M.L.
- Johnson, P.D.R.
- Charles, P.G.P.
Publication date
April 2012
DOI Publisher
European Society of Clinical Infectious Diseases. Published by Elsevier Ltd.Abstract
AbstractWe assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either ‘atypical’ (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens
Add to ORKG